2%更昔洛韦滴眼液对巨细胞病毒阳性青光眼睫状体炎综合征的疗效
前瞻性纳入50例房水CMV阳性的青光眼睫状体炎综合征患者,给予2%更昔洛韦滴眼液每日4次局部治疗,平均5.4周后角膜后沉着物与前房闪光均减少,眼压从26.2±10.9 mmHg降至15.5±3.6 mmHg,糖皮质激素与降眼压药物用量均减少(均P<0.05)。
要点
- 虹膜脱色素、钱币状KP、角膜内皮丢失和发作期高眼压提示CMV阳性PSS。
- 2%更昔洛韦滴眼液每日4次治疗平均5.4周可改善炎症并降低眼压。
- 治疗后激素及降眼压药物用量减少,多数激素依赖者可停用激素。
核心结论
- 2%更昔洛韦滴眼液局部治疗CMV阳性青光眼睫状体炎综合征短期疗效良好,有助于炎性反应和眼压控制。
研究设计与样本
- 前瞻性病例观察研究,2017年8月至2018年1月于复旦大学附属眼耳鼻喉科医院纳入50例临床诊断PSS且房水CMV阳性患者,给予2%更昔洛韦滴眼液每日4次点眼并随访。
主要发现
- 羊脂状或中等大小KP由94%(47/50)减至52%(26/50),钱币状KP由22%(11/50)减至2%(1/50),前房房水闪光由12%(6/50)减至0。
- 眼压由(26.2±10.9)mmHg降至(15.5±3.6)mmHg,激素用量中位数由3次/d减至0次/d,不使用激素比例由6%(3/50)升至60%(30/50)。
- 激素依赖的26例中17例(65%)停用激素,降眼压药种类中位数由2种减至0种,不使用降眼压药比例由24%(12/50)升至58%(29/50),治疗前后差异均有统计学意义(均P<0.05)。
- 接受房水病毒复查的13例患者治疗后CMV DNA全部转为阴性。
关键数值与推荐
- CMV阳性PSS特征包括虹膜脱色素96%(48/50)、钱币状KP、角膜内皮平均丢失率10.8%±5.5%、发作时眼压最高值(47.8±9.9)mmHg。
- 2%更昔洛韦滴眼液局部治疗平均时间为(5.4±2.7)周。
临床怎么用
- 对临床诊断PSS且房水CMV阳性的患者,可考虑2%更昔洛韦滴眼液每日4次局部治疗以控制炎症和眼压、减少激素及降眼压药物用量。
局限性
- 原文为前瞻性病例观察研究,未设对照组,样本量为50例,随访时间短,结论限于短期疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To observe the effect of 2% ganciclovir eye drops on Posner-Schlossman syndrome (PSS) patients with positive cytomegalovirus (CMV) in aqueous humor. Methods: Prospective study. The cases clinically diagnosed as PSS with positive CMV were enrolled from August 2017 to January 2018 at Department of Ophthalmology, Eye & ENT Hospital of Fudan University. All patients underwent aqueous and serum analysis for CMV by the enzyme linked immunosorbent assay and polymerase chain reaction. The history and clinical signs were noted, 2% ganciclovir eye drops were prescribed for topical use (4 times per day), and the patients were followed up. The Pearson Chi-square test was used for the comparison of factors including keratic precipitates (KPs), and the Tyndall, and paired t test or Wilcoxon rank sum test was used for factors like intraocular pressure (IOP), corticoid dosage, and IOP lowering medication dosage. Results: Fifty cases (31 males and 19 females) clinically diagnosed as PSS with positive CMV had an average age of (38±13) years. Some characteristics could help to identify CMV-positive PSS: iris depigmentation (96%, 48/50), coin-shaped KPs, loss of corneal endothelium (an average loss rate of 10.8%±5.5%), and high IOP during attack[(47.8±9.9)mmHg,1 mmHg=0.133 kPa]. After topical antivirus therapy with the mean time of (5.4±2.7) weeks, the clinical manifestations of CMV positive PSS cases improved. The granulomatous or middle-sized KPs decreased from 94%(47/50) to 52%(26/50), the coin-shaped KPs almost disappeared [from 22%(11/50) to 2%(1/50)], and the Tyndall reaction disappeared [from 12%(6/50) to 0]. The mean IOP value decreased from (26.2±10.9) mmHg to (15.5±3.6) mmHg. Furthermore, corticoid use decreased (from 3 times per day to 0 time per day, by median value), the number of cases that did not use corticoids increased from 6% (3 cases) to 60% (30 cases), and 17 (65%) out of those 26 corticoid dependent patients could withdraw corticoids. The number of IOP lowering eye drops used also decreased (from 2 to 0, by median value), and the proportion of cases without IOP lowering medication increased from 24% (12 cases) to 58% (29 cases). There were statistical differences between post-treatment and pre-treameat (all P<0.05).Thirteen cases that accepted CMV re-test of aqueous humor were all CMV DNA negative after treatment. Conclusion: Topical treatment with 2% ganciclovir eye drops has a good short-term effect on CMV-positive PSS patients by contributing to inflammation and IOP control. (Chin J Ophthalmol, 2018, 54: 833-838). 目的: 观察并评价2%更昔洛韦滴眼液治疗巨细胞病毒(CMV)阳性的青光眼睫状体炎综合征患者的临床疗效。 方法: 前瞻性病例观察研究。于2017年8月至2018年1月收集在复旦大学附属眼耳鼻喉科医院眼科就诊的临床表现符合青光眼睫状体炎综合征且房水CMV阳性的患者。采用酶联免疫吸附试验法检测房水及血清中CMV IgG抗体,并行PCR检测CMV DNA以验证ELISA结果。记录患者病史和临床表现,给予2%更昔洛韦滴眼液点眼,4次/d,随访观察疗效。治疗前、后角膜后沉着物(KP)、房水闪光等计数资料比较Pearson χ(2)检验,治疗前、后眼压及糖皮质激素(简称激素)用量、降眼压药用量等计量资料比较采用配对t检验或配对秩和检验。 结果: 共纳入50例(50只眼)患者,其中男性31例,女性19例,年龄(38±13)岁。96%(48/50)的患眼存在虹膜脱色素,患眼相对于健眼的角膜内皮丢失率为10.8%±5.5%、发作时眼压最高值(47.8±9.9)mmHg(1 mmHg=0.133 kPa),并可见特征性钱币状KP。2%更昔洛韦滴眼液局部治疗时间为(5.4±2.7)周。治疗后患者的临床表现均有好转,羊脂状或中等大小KP由94%(47/50)减至52%(26/50);钱币状KP大部分消失,由22%(11/50)减至2%(1/50);前房房水闪光消失,由12%(6/50)减至0;眼压值由(26.2±10.9)mmHg降低至(15.5±3.6)mmHg;而且激素用量由3(0~4)次/d减至0(0~3)次/d,不使用激素的比例由6%(3/50)提高到60%(30/50),原来有激素依赖的26例患者中17例(65%)可以停用激素;降眼压种类由2(0~3)种减至0(0~3)种,不使用降眼压药物的比例由24%(12/50)提高到58%(29/50);治疗后与治疗前比较差异均有统计学意义(均P<0.05)。接受房水病毒复查的13例患者CMV DNA全部转为阴性。 结论: 2%更昔洛韦滴眼液局部治疗CMV阳性的青睫综合征的短期疗效良好,有助于炎性反应和眼压控制。(中华眼科杂志,2018,54:833-838).
引用
- Zhai RY, Xu H, Kong XM, et al. [Effect of 2% ganciclovir eye drops on cytomegalovirus positive Posner-Schlossman syndrome]. Zhonghua Yan Ke Za Zhi. 2018. PMID: 30440154. doi:10.3760/cma.j.issn.0412-4081.2018.11.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。